Latest Breaking News On - Corporal michaelj crescenz va medical center - Page 1 : comparemela.com

Pegozafermin lowers high triglycerides, non-HDL and ApoB vs. placebo in small trial

Pegozafermin, a fibroblast growth factor 21 analog, reduced atherogenic particles in patients with severe hypertriglyceridemia and improved liver fat and insulin resistance compared with placebo, a speaker reported. Michael Miller, MD, FACC, FAHA, chief of medicine at the Corporal Michael J. Crescenz VA Medical Center in Philadelphia and vice chair of medicine at the University of

Healthy Habits Not Outweighed by GLP-1s in OSA

OSA management may be helpful in OSA but raises concerns about access to GLP-1s and abandoning lifestyle changes.

Smoking, high BMI drive relationship between PAD, major depressive disorder

Two local veterans, both dedicated to family, community and country

When the Water Tower Advisory Council was fundraising to refurbish the park, our local VFW Post 5205 answered the call.

DiscGenics Announces Research Collaboration with the U.S. Department of Veterans Affairs for Tissue-Engineered Discs with Discogenic Cells